| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gabriel Perlemuter | |
| Sophie Prevot | |||
| Clement Bresteau | |||
| Cosmin Voican | |||
| P2860 | cites work | High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature | Q27006889 |
| Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines | Q28216281 | ||
| Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period | Q34440712 | ||
| Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature | Q35582456 | ||
| Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report | Q37347316 | ||
| Methylprednisolone-induced liver injury: Case report and literature review | Q38671657 | ||
| Incidence of drug-induced hepatic injuries: a French population-based study | Q39609276 | ||
| Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries | Q40775438 | ||
| Hepatotoxicity of drugs and chemicals | Q43237148 | ||
| Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity | Q44411682 | ||
| Recurrent acute liver toxicity from intravenous methylprednisolone | Q46153825 | ||
| Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury. | Q50182833 | ||
| Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey. | Q53955037 | ||
| ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury | Q60962648 | ||
| Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy | Q61054093 | ||
| Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis | Q79692074 | ||
| Acute hepatitis related to prednisolone | Q81870897 | ||
| Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis | Q83759589 | ||
| P921 | main subject | multiple sclerosis | Q8277 |
| P577 | publication date | 2018-03-05 | |
| P1433 | published in | BMJ case reports | Q27723081 |
| P1476 | title | Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse. | |
| P478 | volume | 2018 |
| Q57807859 | Drug-Induced Liver Injury: Highlights of the Recent Literature |
| Q91973934 | Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review |
| Q90641087 | Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis |
| Q92354443 | Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis |
Search more.